-+ 0.00%
-+ 0.00%
-+ 0.00%

UK’S MHRA: AUTHORISED ORFORGLIPRON (FOUNDAYO), MAKING THE UK THE FIRST COUNTRY IN EUROPE TO APPROVE THIS GLP-1 TABLET FOR WEIGHT MANAGEMENT AND TYPE 2 DIABETES

Reuters·08/10/2026 11:29:07

Please log in to view news